[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid

C21H27N6O7P — CID 175675925

IUPAC[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid
SMILESCNC(=O)[C@H](Cc1ccccc1)NP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)nccc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C21H27N6O7P/c1-23-20(30)13(9-12-5-3-2-4-6-12)26-35(31,32)33-10-15-17(28)18(29)21(34-15)27-11-25-16-14(27)7-8-24-19(16)22/h2-8,11,13,15,17-18,21,28-29H,9-10H2,1H3,(H2,22,24)(H,23,30)(H2,26,31,32)/t13-,15+,17+,18+,21+/m0/s1
InChIKeySEFLMYOTEKPFNS-HXLNDQMISA-N
MW506.46 g/mol
LogP-0.30
Rot. Bonds9

About [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid

[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid (PubChem CID 175675925) has the molecular formula C21H27N6O7P and a molecular weight of 506.46 g/mol. Its IUPAC name is [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid.

Molecular Properties

Compound Name[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid
PubChem CID175675925
Molecular FormulaC21H27N6O7P
Molecular Weight506.46 g/mol
Exact Mass506.17
IUPAC Name[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid
SMILESCNC(=O)[C@H](Cc1ccccc1)NP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)nccc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C21H27N6O7P/c1-23-20(30)13(9-12-5-3-2-4-6-12)26-35(31,32)33-10-15-17(28)18(29)21(34-15)27-11-25-16-14(27)7-8-24-19(16)22/h2-8,11,13,15,17-18,21,28-29H,9-10H2,1H3,(H2,22,24)(H,23,30)(H2,26,31,32)/t13-,15+,17+,18+,21+/m0/s1
InChIKeySEFLMYOTEKPFNS-HXLNDQMISA-N
XLogP-0.30
TPSA194.08 Ų
H-Bond Donors6
H-Bond Acceptors10
Rotatable Bonds9
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500506.46
LogP ≤ 5-0.30
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid?
The IUPAC name of [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid (CID 175675925) is [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid.
What is the SMILES notation for [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid?
The canonical SMILES for [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid is CNC(=O)[C@H](Cc1ccccc1)NP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)nccc32)[C@H](O)[C@@H]1O.
What is the InChIKey of [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid?
The InChIKey is SEFLMYOTEKPFNS-HXLNDQMISA-N. The full InChI is InChI=1S/C21H27N6O7P/c1-23-20(30)13(9-12-5-3-2-4-6-12)26-35(31,32)33-10-15-17(28)18(29)21(34-15)27-11-25-16-14(27)7-8-24-19(16)22/h2-8,11,13,15,17-18,21,28-29H,9-10H2,1H3,(H2,22,24)(H,23,30)(H2,26,31,32)/t13-,15+,17+,18+,21+/m0/s1.
What are the key properties of [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid?
[(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid has a molecular weight of 506.46 g/mol, XLogP of -0.30, 9 rotatable bonds, 6 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3S,4R,5R)-5-(4-aminoimidazo[4,5-c]pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]phosphonamidic acid is sourced from PubChem (CID 175675925), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).